Metraipolis › archive › dc_021b6fbe99a6

Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer — Europe PMC PMID:41174352

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41174352
DOI
10.1002/1878-0261.70152
License (as archived)
solo-consultazione
Archived
2026-11-08T21:57:44.529Z
SHA-256 of the archived text
b03d6e83f4e301f683bf7e7e5aeaa67f96fe77c25128c8644808c4f2640a86ad
Stable URL of this page
https://metraipolis.com/documento/dc_021b6fbe99a6

How to cite

Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer — Europe PMC PMID:41174352 — Europe PMC (en), https://europepmc.org/article/MED/41174352 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_021b6fbe99a6 (Metraipolis archive dc_021b6fbe99a6, sha256 b03d6e83f4e301f683bf7e7e5aeaa67f96fe77c25128c8644808c4f2640a86ad)
BibTeX
@misc{dc021b6fbe99a6,
  title = {Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer — Europe PMC PMID:41174352},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41174352},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_021b6fbe99a6; sha256 b03d6e83f4e301f683bf7e7e5aeaa67f96fe77c25128c8644808c4f2640a86ad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41174352. Agents can read the archived copy with the MCP tool read_document.